FDA emergency use authorization for youth
On Monday May 10, 2021, the U.S. Food and Drug Administration (FDA) granted emergency use authorization for youth aged 12-15 years to receive the Pfizer vaccine. About 17 million youth between the ages of 12 and 15 (or about 5% of the U.S. population) are now eligible to get the Pfizer vaccine. This increases the chances that schools in the U.S. will completely reopen in the fall. It also means that a younger population will now be protected from COVID-19. This decision comes after lots of research and a thorough review of all the available data. Previously, the Pfizer vaccine was only recommended for people 16 years and older. Currently, Pfizer is looking at the safety of its vaccine in younger children through clinical trials.
On Wednesday, May 13, 2021, the Centers for Disease Control (CDC) Advisory Committee decided to recommend the vaccine for this age group. The CDC said there were no serious events linked to the Pfizer shot in 12 – 15 year olds out of more than 2,000 youth in the clinical trials.
Currently, Moderna and Johnson & Johnson vaccines are only recommended for people 18 years and older.